HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2010, 12, 1 (pages: 17 - 24)

Dose Determination in Dual Diagnosed Heroin Addicts during Methadone Treatment

Maremmani I., Pacini M., Canoniero S., Deltito J., Maremmani A. G. I., Tagliamonte A.

Summary: Ninety-nine consecutive responders to treatment for heroin addiction (54 with one or more Axis I psychiatric diagnosis (DD-patients), and 45 without psychiatric comorbidity (NDD-patients), were monitored prospectively (20 months on average, min.1, max. 51), in order to achieve some useful clinical information pertaining to effective methadone dose determination for double diagnosed heroin addicts. First day and first month dosages do not differ between the two groups. Stabilization dosages are higher in DD patients than in NDD patients. The time to reach stabilization phase is longer in DD patients than in NDD patients. Tapering of methadone follows a similar trend in both groups. DD patients need more attention from clinicians, especially when stabilization dosage has to be established.

 

AU-CNS Associazione per lā€™Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 ā€“ 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 ā€“ Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page